Target intelligence / Profile preview

Sequestosome-1 ZZ domain (p62 ZZ domain)

Target
p62 ZZ domain
Molecular classification
Zinc finger domain, N-recognin (N-end rule pathway), Autophagy adapter binding domain
01

Overview

The Sequestosome-1 ZZ domain (p62 ZZ domain) is a zinc finger domain within the Sequestosome-1 (SQSTM1/p62) protein that specifically recognizes and binds type-1 and type-2 N-degrons, including N-terminal arginine (Nt-Arg), as part of the N-end rule pathway for targeted protein degradation. This domain is structurally and functionally homologous to the UBR box of classic N-recognins, but employs a distinct binding mode for substrate recognition. The p62 ZZ domain is essential for the aggregation of p62 and its cargo, facilitating their delivery to autophagosomes for lysosomal degradation, a process critical for cellular homeostasis and stress response. It also contributes to the regulation of mTORC1 signaling and may modulate p62's own function through intramolecular interactions with a regulatory linker sequence. Mutations in the ZZ domain and its neighboring regions have been implicated in neurodegenerative diseases such as amyotrophic lateral sclerosis, highlighting its importance in protein quality control and cellular health. The domain acts as a multiprotein and RNA interaction hub, linking the ubiquitin-proteasome system with selective autophagy pathways.

Other names
SQSTM1 ZZ domainp62/SQSTM1 ZZ domainN-recognin homologous to UBR box
02

Biological functions

Selective autophagy (aggrephagy)N-end rule substrate recognitionProtein aggregation and cargo recruitment for autophagyModulation of mTORC1 signalingCellular stress response
03

Disease associations

Neurodegenerative disease (e.g., amyotrophic lateral sclerosis)CancerPaget's disease of bone (when SQSTM1/p62 is mutated)Other diseases involving autophagy or protein aggregation pathology

Beyond the preview

Go deeper on Sequestosome-1 ZZ domain (p62 ZZ domain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sequestosome-1 ZZ domain (p62 ZZ domain).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call